Tecan to acquire Paramit Corporation, a leading OEM developer and manufacturer of medical devices and life sciences instruments, for a total consideration of USD 1.0 billion (CHF 920 million) In full year 2021, Paramit is expected to generate around USD 280m in sales (CHF 257m) and around USD 50m EBITDA (CHF 46m), before acquisition-related costs Transaction expected to be immediately and significantly accretive to earnings per share (EPS) upon closing Adds complementary expertise, broadens design, development and manufacturing capabilities Expansion into the attractive and fast–growing medical […]
Solutions to complement Company’s growing position in cell and gene therapy research and development WALTHAM, Mass. — PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) is pleased to announce it has entered into an agreement to acquire SIRION Biotech GmbH, a leading, global provider of viral vector-based technologies that drive improved delivery performance for cell and gene therapies. The acquisition is […]
WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Toulouse, France based Polymem S.A. (“Polymem”), a leading industrial expert in the development and manufacture of hollow fiber membranes and modules. Tony J. Hunt, President and CEO of Repligen, […]
Saluggia – DiaSorin (FTSE MIB: DIA) announces that the Shareholders’ Meeting of Luminex Corporation (“Luminex”; NASDAQ: LMNX), held today, approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin, pursuant to the merger agreement relating to the acquisition of Luminex by DiaSorin, as announced on April 11, 2021. Following the merger, Luminex shareholders […]
Saluggia – DiaSorin (FTSE MIB: DIA) announces that the Shareholders’ Meeting of Luminex Corporation (“Luminex”; NASDAQ: LMNX), held today, approved the merger of Luminex with a U.S. wholly-owned subsidiary of DiaSorin, pursuant to the merger agreement relating to the acquisition of Luminex by DiaSorin, as announced on April 11, 2021. Following the merger, Luminex shareholders […]
Aldevron is a leader in manufacturing high-quality plasmid DNA, mRNA and recombinant proteins Aldevron’s products empower biotech companies to achieve scientific and medical breakthroughs During EQT’s ownership, Aldevron has experienced strong organic growth and made significant investments to position itself for further expansion EQT is pleased to announce that the EQT VIII fund (“EQT Private […]
BOSTON — Artemis Capital Partners (“Artemis”), a Boston-based private equity firm focused exclusively on partnering with differentiated industrial technology companies, completed the successful sale of its portfolio company, BioDot (“the Company”) to ATS Automation Tooling Systems Inc. (TSX: ATA). BioDot Since its founding in 1994, BioDot has become an undisputed leader in the development of automated, […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (the “Company”) announced today that Danaher has entered into a definitive agreement to acquire privately-held Aldevron, for a cash purchase price of approximately $9.6 billion. Danaher expects to finance the acquisition using cash on hand and/or proceeds from the issuance of commercial paper. Founded in 1998 by Michael Chambers and John Ballantyne, Aldevron is headquartered […]
Oxford Instruments plc (“the Group”), a leading provider of high-technology solutions, information and services for industry and research, today announces the acquisition of WITec Wissenschaftliche Instrumente und Technologie GmbH, a leading provider of Raman microscopy imaging solutions, based in Ulm, Germany, for a cash-free, debt-free consideration of €42m, of which €5m is conditional on trading […]
CALIBRE SCIENTIFIC ACQUIRES LINARIS BIOLOGISCHE PRODUKTE TO EXPAND PRODUCT PORTFOLIO AND CUSTOMER REACH IN THE DACH REGION LOS ANGELES — Calibre Scientific is pleased to announce the acquisition of LINARIS Biologische Produkte GmbH (“LINARIS”), a life science distributor with headquarters outside of Frankfurt, Germany. LINARIS will be integrated with BIOZOL Diagnostica GmbH, a subsidiary of Calibre Scientific, enhancing […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
